Texts and calls could be key to beating high blood pressure in nepal

NCT ID NCT05979168

Recruiting now Disease control Sponsor: Central Department of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests whether regular phone calls and text messages with lifestyle advice can help adults in Nepal with uncontrolled high blood pressure lower their numbers. Five hundred participants will receive either the mobile health program or usual care for six months. The goal is to see if this simple, low-cost approach improves blood pressure control and reduces heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: phone calls and text messages with lifestyle counseling
What this could lead to: If it works, this could offer a low-cost way to help people in low-resource settings better control their blood pressure and lower their risk of heart disease.
What could go wrong: This is a single-country trial with 500 participants, so results may not apply everywhere. The intervention relies on participants having and using a mobile phone, which may limit who benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder hypertensive disorder Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD PRESSURE CARDIOVASCULAR DISEASES HYPERTENSION MEDICATION ADHERENCE

Contacts and locations

Locations

Apara Innovations Pvt Ltd
RECRUITING

Kathmandu, Pradesh 3 (Bagmati), 40660, Nepal
Sahid Gangalal National Heart Center
RECRUITING

Kathmandu, Bagmati, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.